Toronto, ON – A recent study by Dr Kieran J Murphy at the University Health Network found that a unique formulation of antioxidants administered to patients prior to subjecting them to imaging techniques involving radiation decreased the damaging effects of the radiation exposure.
The results of this study were presented at the recent scientific meeting of the Society of Interventional Radiology in Chicago. In what the researchers say is the first clinical trial of its kind, as much as a 50 percent reduction in DNA injury was observed after administering the formula prior to CT scans.
“In our initial small study, we found that pre-administering to patients a proprietary antioxidant formulation resulted in a notable dose-dependent reduction in DNA injury,” said Kieran J Murphy, MD, FSIR, who is professor and vice chair, director of research and deputy chief of radiology at the University of Toronto and University Health Network in Toronto.
“Pre-administering this formula before a medical imaging exam may be one of the most important tools to provide radioprotection and especially important for patients in the getting CT scans,” he said. The study’s data support the theory about a protective effect during these kinds of exposure, he explained.
“There is currently a great deal of controversy in determining the cancer risks associated with medical imaging exams. Although imaging techniques, such as CT scans and mammograms, provide crucial and often life-saving information to doctors and patients, they work by irradiating people with X-rays, and there is some evidence that these can, in the long run, cause cancer,” he said.
The small study showed that even though many antioxidants are poorly absorbed by the body, one particular mixture was effective in protecting against the specific type of injury caused by medical imaging exams. People are 70 percent water, and X-rays collide with water molecules to produce free radicals (groups of atoms with an unpaired number of electrons that are dangerous when they react with cellular components, causing damage and even cell death) that can go on to do damage by direct ionization of DNA and other cellular targets. The research team evaluated whether a special combination of antioxidants have an ability to neutralize these free radicals before they can do damage.
“Our intent was to develop an effective proprietary formula of antioxidants to be taken orally prior to exposure that can protect a patient’s DNA against free radical mediated radiation injury, and we have applied to patent this formulation and a specific dose strategy,” said Dr Murphy.
The experiments measured DNA damage as a surrogate marker for DNA injury. Blood was drawn from two study volunteers in duplicate, creating four individual tests per data point. DNA strand breaks are repaired by a big protein complex that binds to the site of the damage. The researchers labeled one of the proteins with a fluorescent tag. Then, under a 3-D microscope, the DNA is examined for signs of repair. The more repair that is seen, the more DNA damage must have been done by the CT scan to initiate that repair. The experiments clearly showed a reduction of DNA repair in the treatment group, which means that there was less DNA injury as a result of pre-administering the antioxidant mixture, said Murphy.
The researchers concede that this is a small study and that a lot more research needs to be done; however, these initial results point toward a positive future for this kind of treatment. The group says the next step is a clinical trial in Toronto.
The presentation was Poster 266: “Antioxidants Taken Orally Prior to Radiation Exposure Can Prevent DNA Injury at CT Doses of Ionizing Radiation,” J Barfett; Stephanie Spieth, K J Murphy and D J Mikulis; all from the department of medical imaging, University of Toronto, Ontario, Canada, SIR 36th Annual Scientific Meeting March 26-31, Chicago, Ill. The abstract can be found at www.SIRmeeting.org.